Literature DB >> 32266089

A comprehensive review of the roles of E2F1 in colon cancer.

Zejun Fang1,2, Min Lin1, Chunxiao Li3, Hong Liu4,5, Chaoju Gong6.   

Abstract

E2F transcription factor 1 (E2F1) is a member of the E2F family of transcription factors. E2F1 binds to DNA with dimerization partner (DP) proteins through an E2 recognition site. The dissociation of E2F1 from retinoblastoma (Rb) protein recovers its transcriptional activity, which drives the cell cycle from the G1 to S phase. E2F1 has been shown to be involved in cellular proliferation, differentiation, and apoptosis in colon cancer. It was recently found that E2F1 also participates in the metastasis and chemoresistance of colon cancer. There are abundant experimental data regarding the actions of E2F1, which can be grouped as either pro-tumorigenic or pro-apoptotic. Despite a growing interest and plentiful data, there is currently no review that focuses on the role of E2F1 in colon cancer. Research on E2F1 and colon cancer has been scattered over various genes and microRNAs (miRNAs) that affect E2F1 expression. Here, we provide the first review that aims to consider and dissect all of the elucidated complex behaviors of E2F1 in colon cancer. This review also provides an analysis and conclusion regarding the current understanding of E2F1 in colon cancer in order to facilitate the direction of future research. AJCR
Copyright © 2020.

Entities:  

Keywords:  E2F1; apoptosis; chemoresistance; colon cancer; proliferation

Year:  2020        PMID: 32266089      PMCID: PMC7136928     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  105 in total

1.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

2.  Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells.

Authors:  Shu Gong; Dongsheng Xu; Jialin Zhu; Fangdong Zou; Rui Peng
Journal:  Cell Physiol Biochem       Date:  2018-05-22

3.  In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer.

Authors:  Sabrina Bochicchio; Barbara Dapas; Ilaria Russo; Carolina Ciacci; Ornella Piazza; Stefaan De Smedt; Eline Pottie; Anna Angela Barba; Gabriele Grassi
Journal:  Int J Pharm       Date:  2017-02-09       Impact factor: 5.875

4.  Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Authors:  D Salonga; K D Danenberg; M Johnson; R Metzger; S Groshen; D D Tsao-Wei; H J Lenz; C G Leichman; L Leichman; R B Diasio; P V Danenberg
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

5.  The E2F family and the role of E2F1 in apoptosis.

Authors:  Zhenlong Wu; Shunsheng Zheng; Qiang Yu
Journal:  Int J Biochem Cell Biol       Date:  2009-06-17       Impact factor: 5.085

6.  Non-digestible fraction of beans (Phaseolus vulgaris L.) modulates signalling pathway genes at an early stage of colon cancer in Sprague-Dawley rats.

Authors:  Vergara-Castañeda Haydé; Guevara-González Ramón; Guevara-Olvera Lorenzo; Oomah B Dave; Reynoso-Camacho Rosalía; Wiersma Paul; Loarca-Piña Guadalupe
Journal:  Br J Nutr       Date:  2012-08       Impact factor: 3.718

7.  Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis.

Authors:  Gabriel De Leon; Tara C Sherry; Nancy A Krucher
Journal:  Cancer Biol Ther       Date:  2008-03-05       Impact factor: 4.742

8.  Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.

Authors:  Karin Birkenkamp-Demtröder; Stephan A Hahn; Francisco Mansilla; Kasper Thorsen; Abdelouahid Maghnouj; Rikke Christensen; Bodil Øster; Torben Falck Ørntoft
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 9.  Expressions and prognostic values of the E2F transcription factors in human breast carcinoma.

Authors:  Ze-Long Liu; Xi-Wen Bi; Pan-Pan Liu; De-Xin Lei; Yu Wang; Zhi-Ming Li; Wen-Qi Jiang; Yi Xia
Journal:  Cancer Manag Res       Date:  2018-09-13       Impact factor: 3.989

10.  siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.

Authors:  Ilaria Russo; Albino Carrizzo; Sabrina Bochicchio; Ornella Piazza; Gaetano Lamberti; Anna Angela Barba; Carmine Vecchione; Pio Zeppa; Paola Iovino; Cristina Bucci; Antonella Santonicola; Carolina Ciacci
Journal:  Transl Med UniSa       Date:  2018-03-31
View more
  26 in total

1.  Identification of key regulators associated with colon cancer prognosis and pathogenesis.

Authors:  Narges Toolabi; Fattane Sam Daliri; Amir Mokhlesi; Mahmood Talkhabi
Journal:  J Cell Commun Signal       Date:  2021-03-26       Impact factor: 5.782

2.  Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.

Authors:  Salvador Guardiola; Macarena Sánchez-Navarro; Rafael Rosell; Ernest Giralt; Jordi Codony-Servat
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

3.  Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1.

Authors:  Eun Jae Yang; Ji Hwan Park; Hyun-Ji Cho; Jeong-A Hwang; Seung-Hwa Woo; Chi Hyun Park; Sung Young Kim; Joon Tae Park; Sang Chul Park; Daehee Hwang; Young-Sam Lee
Journal:  Commun Biol       Date:  2022-07-14

Review 4.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

5.  Identification and verification of the role of crucial genes through which methionine restriction inhibits the progression of colon cancer cells.

Authors:  Liqiang Zhou; Zhiqing Chen; Chuan Liu
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

Review 6.  Emerging roles for lncRNA-NEAT1 in colorectal cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Omid Anbiyaee; Riyadh Ahmad Ali; Maryam Cheraghzadeh; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2022-06-08       Impact factor: 6.429

7.  Sevoflurane Offers Neuroprotection in a Cerebral Ischemia/Reperfusion Injury Rat Model Through the E2F1/EZH2/TIMP2 Regulatory Axis.

Authors:  Lihua Yang; Hongfei Chen; Lina Guan; Yucan Xu
Journal:  Mol Neurobiol       Date:  2022-01-22       Impact factor: 5.590

8.  xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.

Authors:  Bufu Tang; Jinyu Zhu; Fangming Liu; Jiayi Ding; Yajie Wang; Shiji Fang; Liyun Zheng; Rongfang Qiu; Minjiang Chen; Gaofeng Shu; Min Xu; Chenying Lu; Zhongwei Zhao; Yang Yang; Jiansong Ji
Journal:  Cell Death Dis       Date:  2022-04-19       Impact factor: 9.685

9.  Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma.

Authors:  Yaqin Xu; Yingying Dong; Yunhua Deng; Qianrong Qi; Mi Wu; Hongmei Liang; Qiuyun She; Qing Guo
Journal:  Biology (Basel)       Date:  2021-05-13

Review 10.  A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Authors:  Brianna M Quinville; Natalie M Deschenes; Alex E Ryckman; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.